Tuesday, April 23
12:15 pm – 1:15 pm
PCC North, 100 Level, Ballroom 120 D
Molly M. Stevens, Imperial College London
Bio-Responsive Hybrid Materials
Bio-responsive hybrid materials are of growing importance with potential applications including drug delivery, diagnostics and tissue engineering. A side effect of longer lifespans is the failure of one part of the body. The search for replacement body parts has fuelled the highly interdisciplinary field of tissue engineering and regenerative medicine. This talk will describe our research on the design of new hybrid (nano)materials and nanomaterials to direct stem cell differentiation for regenerative medicine. We have also designed and developed porous silicon “nanoneedles” capable of efficiently, rapidly and safely delivering sensitive biocargoes to cells and tissues in vivo as well as interfacing with cells to inform intracellular pH and high-resolution demarcation of tumorous region boundaries. This talk will also provide an overview of our recent developments in the design of materials for ultrasensitive biosensing, applying these nanomaterial-based approaches to high throughput drug screening and to diagnose diseases.
About Molly M. Stevens
Molly M. Stevens is currently Professor of Biomedical Materials and Regenerative Medicine, Research Director for Biomedical Material Sciences in the Department of Materials, Department of Bioengineering and the Institute of Biomedical Engineering at Imperial College London, and Director of the United Kingdom Regenerative Medicine Programme Hub for Smart Materials. Stevens received her PhD degree from The University of Nottingham in 2000, then did postdoctoral research at the Massachusetts Institute of Technology (MIT) in the laboratory of Professor Robert Langer, where she co-developed innovative techniques for the regeneration of bone and other tissues. She joined Imperial College in 2004 and was promoted to Full Professor in 2008. Research in the Stevens Programme focuses on designing and developing innovative bioinspired materials for applications in regenerative medicine, tissue engineering and biosensing. Stevens' research has been recognized by over 20 major awards. More information on the Stevens Group can be found at stevensgroup.org.